Amalgamated Bank’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.19M Sell
32,743
-2,049
-6% -$150K 0.02% 779
2026
Q1
$2.65M Sell
34,792
-1,317
-4% -$94.9K 0.02% 681
2025
Q4
$2.31M Buy
36,109
+14,331
+66% +$883K 0.02% 758
2025
Q3
$1.37M Sell
21,778
-513
-2% -$35.8K 0.01% 952
2025
Q2
$1.66M Buy
22,291
+168
+0.8% +$13.2K 0.01% 853
2025
Q1
$1.95M Sell
22,123
-295
-1% -$27.9K 0.02% 780
2024
Q4
$2.05M Sell
22,418
-554
-2% -$56.8K 0.02% 788
2024
Q3
$2.57M Sell
22,972
-15,109
-40% -$1.51M 0.02% 707
2024
Q2
$3.73M Buy
38,081
+168
+0.4% +$16.7K 0.03% 566
2024
Q1
$3.8M Buy
37,913
+5,802
+18% +$510K 0.03% 596
2023
Q4
$2.88M Buy
32,111
+321
+1% +$25.6K 0.02% 765
2023
Q3
$2.44M Buy
31,790
+1,048
+3% +$87K 0.02% 797
2023
Q2
$2.57M Sell
30,742
-612
-2% -$49.8K 0.02% 779
2023
Q1
$2.64M Sell
31,354
-10,402
-25% -$893K 0.02% 763
2022
Q4
$3.4M Buy
41,756
+8,588
+26% +$692K 0.03% 692
2022
Q3
$2.36M Sell
33,168
-2,585
-7% -$232K 0.02% 767
2022
Q2
$3.21M Buy
35,753
+2,090
+6% +$216K 0.03% 660
2022
Q1
$3.77M Sell
33,663
-2,536
-7% -$297K 0.03% 637
2021
Q4
$4.38M Sell
36,199
-8,426
-19% -$937K 0.03% 581
2021
Q3
$4.5M Sell
44,625
-1,295
-3% -$143K 0.04% 562
2021
Q2
$5.36M Buy
45,920
+38,515
+520% +$4.62M 0.04% 518
2021
Q1
$815K Sell
7,405
-273
-4% -$29.6K 0.03% 697
2020
Q4
$770K Sell
7,678
-18
-0.2% -$1.67K 0.03% 709
2020
Q3
$601K Sell
7,696
-177
-2% -$13.3K 0.03% 738
2020
Q2
$548K Sell
7,873
-12,077
-61% -$761K 0.03% 783
2020
Q1
$929K Sell
19,950
-758
-4% -$48.7K 0.02% 649
2019
Q4
$1.64M Buy
20,708
+1,229
+6% +$94.5K 0.03% 594
2019
Q3
$1.44M Sell
19,479
-390
-2% -$28K 0.03% 597
2019
Q2
$1.55M Buy
19,869
+2,012
+11% +$153K 0.04% 555
2019
Q1
$1.35M Buy
17,857
+479
+3% +$38.1K 0.03% 581
2018
Q4
$1.27M Sell
17,378
-433
-2% -$34.5K 0.04% 533
2018
Q3
$1.71M Sell
17,811
-536
-3% -$53.1K 0.04% 437
2018
Q2
$1.83M Buy
18,347
+500
+3% +$52.8K 0.04% 431
2018
Q1
$1.88M Sell
17,847
-456
-2% -$46.1K 0.05% 403
2017
Q4
$1.7M Buy
18,303
+1,611
+10% +$146K 0.05% 440
2017
Q3
$1.51M Buy
16,692
+292
+2% +$24.9K 0.05% 423
2017
Q2
$1.38M Buy
16,400
+6,045
+58% +$487K 0.05% 450
2017
Q1
$837K Buy
10,355
+598
+6% +$47K 0.04% 531
2016
Q4
$734K Buy
9,757
+2,791
+40% +$202K 0.03% 638
2016
Q3
$471K Buy
6,966
+36
+0.5% +$2.42K 0.03% 775
2016
Q2
$453K Buy
6,930
+1,475
+27% +$108K 0.03% 782
2016
Q1
$394K Buy
5,455
+1,404
+35% +$92K 0.04% 693
2015
Q4
$273K Sell
4,051
-1,236
-23% -$86.5K 0.03% 853
2015
Q3
$342K Buy
5,287
+157
+3% +$11.6K 0.04% 785
2015
Q2
$420K Sell
5,130
-66
-1% -$5.09K 0.04% 700
2015
Q1
$360K Buy
5,196
+1,208
+30% +$87.2K 0.04% 581
2014
Q4
$303K Sell
3,988
-583
-13% -$46.1K 0.05% 578
2014
Q3
$370K Buy
4,571
+253
+6% +$21.1K 0.06% 489
2014
Q2
$377K Buy
4,318
+366
+9% +$31.8K 0.06% 485
2014
Q1
$341K Sell
3,952
-78
-2% -$6.39K 0.06% 493
2013
Q4
$325K Buy
+4,030
New +$313K 0.06% 517

Other funds holding EMN

Amalgamated Bank's EMN Position: Q2 2026 in Review

Amalgamated Bank reduced its Eastman Chemical (EMN) stake by 5.9% in Q2 2026, selling an estimated $150K and leaving 32,743 shares worth $2.19M. The position accounts for 0.02% of the portfolio, ranked #779.

Amalgamated Bank first reported a position in EMN in Q4 2013 and has held it in 51 quarters since. The position peaked at $5.36M in Q2 2021. 347 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Amalgamated Bank held 32,743 shares of Eastman Chemical worth $2.19M as of Q2 2026.
  • Amalgamated Bank sold 2,049 Eastman Chemical shares in Q2 2026, an estimated $150K.
  • Eastman Chemical made up 0.02% of Amalgamated Bank's portfolio in Q2 2026, its #779 holding.
  • Amalgamated Bank first reported a position in Eastman Chemical in Q4 2013 and has held it in 51 quarters since.
  • Amalgamated Bank's Eastman Chemical position peaked at $5.36M in Q2 2021.
  • 347 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.